Zotefoams plc
Delayed Preliminary Results
23 March 2020 - Zotefoams plc ("Zotefoams") a world leader in cellular material technology, today announces a delay in the publication of its preliminary results at the request of the Financial Conduct Authority (FCA).
Zotefoams plc was ready to release its preliminary financial results on 24 March 2020.
The FCA has strongly requested that all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks from today's date.
Zotefoams plc will be observing this moratorium. Further information on a revised timetable for publication of our preliminary financial statements will follow when further guidance from the FCA and other regulatory authorities is available.
Enquiries:
Zotefoams plc |
|
+44 (0) 208 664 1600 |
David Stirling, Group CEO |
|
|
Gary McGrath, Group CFO |
|
|
|
|
|
IFC Advisory (Financial PR & IR) |
|
+44 (0) 203 934 6630 |
Graham Herring Zach Cohen |
|
|
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.
www.zotefoams.com
AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc
